JP2024544960A5 - - Google Patents
Info
- Publication number
- JP2024544960A5 JP2024544960A5 JP2024527754A JP2024527754A JP2024544960A5 JP 2024544960 A5 JP2024544960 A5 JP 2024544960A5 JP 2024527754 A JP2024527754 A JP 2024527754A JP 2024527754 A JP2024527754 A JP 2024527754A JP 2024544960 A5 JP2024544960 A5 JP 2024544960A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- item
- composition
- bacterial strain
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278134P | 2021-11-11 | 2021-11-11 | |
| US63/278,134 | 2021-11-11 | ||
| PCT/US2022/079637 WO2023086883A1 (en) | 2021-11-11 | 2022-11-10 | Microbial compositions for the treatment of skin diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544960A JP2024544960A (ja) | 2024-12-05 |
| JP2024544960A5 true JP2024544960A5 (https=) | 2025-11-18 |
Family
ID=86336611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527754A Pending JP2024544960A (ja) | 2021-11-11 | 2022-11-10 | 皮膚疾患の処置のための微生物組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US12115197B2 (https=) |
| EP (1) | EP4429683A1 (https=) |
| JP (1) | JP2024544960A (https=) |
| KR (1) | KR20240117164A (https=) |
| CN (1) | CN118541163A (https=) |
| AU (1) | AU2022388745A1 (https=) |
| CA (1) | CA3237750A1 (https=) |
| WO (1) | WO2023086883A1 (https=) |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2660645C (en) | 2006-08-11 | 2016-04-05 | Novozymes Biologicals, Inc. | Bacillus cultures for use in washing, cleaning, stain removal, or degrading waste materials |
| KR100878799B1 (ko) * | 2007-03-13 | 2009-01-14 | 한국생명공학연구원 | 항생제 내성 병원성 미생물 또는 장내 유해 미생물의생장을 억제하는 바실러스 아밀로리퀴페시언스 ｋ317 |
| JP2016509003A (ja) * | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
| US20160073642A1 (en) | 2013-05-03 | 2016-03-17 | Universidad Eafit | Production process for biomass and fengycin metabolites of bacillus species and compositions thereof for biological pest control |
| US20180289751A1 (en) * | 2015-05-05 | 2018-10-11 | The Regents Of The University Of California | Antimicrobial therapy |
| WO2018049182A2 (en) | 2016-09-08 | 2018-03-15 | Locus Solutions, Llc | Distributed systems for the efficient production and use of microbe-based compositions |
| KR20190140063A (ko) | 2017-05-07 | 2019-12-18 | 로커스 아이피 컴퍼니 엘엘씨 | 피부 건강을 위한 화장품 조성물 및 이를 사용하는 방법 |
| EP3784807B1 (en) | 2018-04-23 | 2025-06-04 | Evonik Operations GmbH | Synbiotic compositions |
| US20220096574A1 (en) | 2019-01-29 | 2022-03-31 | Holobiome, Inc. | Methods and compositions for treating and preventing central nervous system disorders and other conditions caused by gut microbial dysbiosis |
| JP7689077B2 (ja) | 2019-02-11 | 2025-06-05 | エボニック オペレーションズ ゲーエムベーハー | バシラエン産生細菌またはその調製物を含有する組成物 |
| MX2021012558A (es) * | 2019-04-17 | 2022-01-04 | Andes Ag Inc | Metodos innovadores para el tratamiento de las semillas y componentes para mejorar los atributos y el rendimiento de la planta. |
| BR112021023020A2 (pt) | 2019-05-20 | 2022-01-04 | Evonik Operations Gmbh | Uso de ésteres de poliglicerol como carreador para ingredientes microbiológicos ativos |
| MX2021015725A (es) | 2019-06-19 | 2022-04-01 | Basf Corp | Formulaciones agroquimicas acuosas que comprenden esporas de bacterias. |
| GB201911925D0 (en) | 2019-08-20 | 2019-10-02 | Sporegen Ltd | Formulations for prevention or reduction of c. difficile infections |
| CA3187427A1 (en) | 2020-06-17 | 2021-12-23 | Bioconsortia, Inc. | Agriculturally beneficial microbes, microbial compositions, and consortia |
| EP4223301A1 (en) | 2020-09-07 | 2023-08-09 | Il Dong Pharmaceutical Co., Ltd. | Composition for preventing or treating periodontal diseases, comprising bacillus velezensis strain, culture medium thereof, or culture supernatant thereof as active ingredient |
| JP2023543355A (ja) | 2020-09-25 | 2023-10-13 | バイオームエディット・エルエルシー | プロバイオティックバチルス属組成物及び使用方法 |
| WO2022119895A1 (en) | 2020-12-01 | 2022-06-09 | Dupont Us Holding, Llc | Methods and compositions for microbial treatment of skin disorders |
| IL305939A (en) | 2021-03-14 | 2023-11-01 | The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo | Bacillus antibacterial agents |
| WO2022226376A2 (en) | 2021-04-22 | 2022-10-27 | Indigo Ag, Inc. | Endophyte compositions and methods for improved plant health |
| WO2023091342A1 (en) | 2021-11-16 | 2023-05-25 | Phibro Animal Health Corporation | Preservation system for stabilizing spore-forming microbials |
-
2022
- 2022-11-10 KR KR1020247018262A patent/KR20240117164A/ko active Pending
- 2022-11-10 EP EP22893839.5A patent/EP4429683A1/en active Pending
- 2022-11-10 AU AU2022388745A patent/AU2022388745A1/en active Pending
- 2022-11-10 WO PCT/US2022/079637 patent/WO2023086883A1/en not_active Ceased
- 2022-11-10 JP JP2024527754A patent/JP2024544960A/ja active Pending
- 2022-11-10 CN CN202280088350.0A patent/CN118541163A/zh active Pending
- 2022-11-10 CA CA3237750A patent/CA3237750A1/en active Pending
-
2024
- 2024-02-28 US US18/589,539 patent/US12115197B2/en active Active
- 2024-09-05 US US18/825,396 patent/US12329787B2/en active Active
-
2025
- 2025-05-12 US US19/205,443 patent/US20250268955A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hicks et al. | Co-carcinogenic action of saccharin in the chemical induction of bladder cancer | |
| EP3139939B1 (en) | Compositions and methods for treating skin and mucous membrane diseases | |
| Brook et al. | Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci: A prospective randomized study comparing penicillin, erythromycin, and clindamycin | |
| AU2010308741B2 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| US20080089963A1 (en) | Topical compositions containing Bacillus coagulans extracellular products and uses thereof | |
| CA3195341A1 (en) | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes | |
| GB2588721A (en) | Compositions for the treatment of skin conditions | |
| US11766465B2 (en) | External composition for wound healing containing lactobacillus fermentation product and method for promoting wound healing using the same | |
| CN111701011A (zh) | 宿主防御肽组合物及其在制备抗菌药物中的应用 | |
| CN116350529B (zh) | 用于改善或维持哺乳动物皮肤健康的方法和组合物 | |
| Ganança et al. | The therapeutic effects of cyclacillin in acute sinusitis: in vitro and in vivo correlations in a placebo-controlled study | |
| JP2024544960A5 (https=) | ||
| CN114470007A (zh) | 含乳酸菌发酵产物之创伤外用组合物及其用途 | |
| CN119120262A (zh) | 一株植物乳植杆菌jnl0074、其应用以及一种微生物菌剂 | |
| CN109954004B (zh) | 脆弱拟杆菌提取物在制备防治银屑病的组合物中的应用 | |
| CN116083294B (zh) | 罗伊氏乳杆菌及在制备预防或治疗子痫前期的制剂产品中的应用 | |
| US9408868B2 (en) | Skin external composition comprising a combination of sodium chloride and glucose as active ingredients for treating vaginosis and the use thereof | |
| Salo et al. | Efficacy and tolerability of erythromycin acistrate and erythromycin stearate in acute skin infections of patients with atopic eczema | |
| CN116650533A (zh) | 普拉梭菌在制备预防、改善和/或治疗急性胰腺炎的产品中的应用 | |
| Nolting et al. | Treatment of Impetigo and Ecthyma. | |
| US4459307A (en) | Antibacterial drug | |
| CN109954005B (zh) | 脆弱拟杆菌提取物在制备防治过敏性皮炎的组合物中的应用 | |
| Chaudhari et al. | Role of probiotics in the management of fungal infections | |
| CN113768919B (zh) | 木犀草素在增效没食子酸烷基酯类化合物抗金黄色葡萄球菌作用中的新用途 | |
| WO2025108208A1 (zh) | 用于改善或维持皮肤、毛囊、头皮或毛发健康的方法和组合物 |